Publicaciones (294) Publicaciones de Juan Manuel Irache Garreta

2024

  1. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab

    Drug Delivery and Translational Research, Vol. 14, Núm. 5, pp. 1189-1205

  2. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles

    Frontiers in Immunology, Vol. 15

2023

  1. 3D printing of microencapsulated Lactobacillus rhamnosus for oral delivery

    International Journal of Pharmaceutics, Vol. 641

  2. Editorial: Protein nanoparticles: characterization and pharmaceutical application

    Frontiers in Pharmacology

  3. Encapsulation of Lactobacillus plantarum in casein-chitosan microparticles facilitates the arrival to the colon and develops an immunomodulatory effect

    Food Hydrocolloids, Vol. 136

  4. Gliadin nanoparticles for oral administration of bioactives: Ex vivo and in vivo investigations

    International Journal of Biological Macromolecules, Vol. 249

  5. Nanoparticle-based products: An example of complex dosage forms

    Time-Proof Perspectives on Bioequivalence (Nova Science Publishers, Inc.), pp. 253-273

  6. Optimization of Enterotoxigenic Escherichia coli (ETEC) Outer Membrane Vesicles Production and Isolation Method for Vaccination Purposes

    Microorganisms, Vol. 11, Núm. 8

  7. Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin

    International Journal of Pharmaceutics, Vol. 643

2022

  1. Development of a Bacterial Nanoparticle Vaccine Against Escherichia coli

    Methods in Molecular Biology (Humana Press Inc.), pp. 357-365

  2. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

  3. Immune Response after Skin Delivery of a Recombinant Heat-Labile Enterotoxin B Subunit of Enterotoxigenic Escherichia coli in Mice

    Pharmaceutics, Vol. 14, Núm. 2

  4. Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN–Mannosamine Polymer Conjugate

    Pharmaceutics, Vol. 14, Núm. 1

  5. Oral administration of zein-based nanoparticles reduces glycemia and improves glucose tolerance in rats

    International Journal of Pharmaceutics, Vol. 628

  6. Zein-Based Nanoparticles as Oral Carriers for Insulin Delivery

    Pharmaceutics, Vol. 14, Núm. 1

2021

  1. 3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

    Acta Tropica, Vol. 215

  2. Caenorhabditis elegans as a model under hyperglicemic conditions to evaluate insulin-loaded nanoparticles

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 202-204

  3. Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection

    Nanoscale, Vol. 13, Núm. 41, pp. 17486-17503

  4. Development of nanostructured systems using natural polymers to optimize the treatment of inflammatory bowel diseases: A prospective study

    Journal of Drug Delivery Science and Technology, Vol. 64

  5. Experimental vaccination with nanoparticles containing Escherichia coli virulence factors

    Applications of Nanobiotechnology for Neglected Tropical Diseases (Elsevier), pp. 3-27